For the first time in 20 years, the FDA has approved two transformative new treatments for the approximately 100,000 people with sickle cell disease (SCD). One new med will prevent the excruciating pain of SCD while the other is formulated to prevent organ damage. “After decades of waiting, there is now a treatment option that… [Read More]
Milwaukee Times Weekly Newspaper
Journalistic Excellence, Service, Integrity and Objectivity Always
FridayNovember 27th, 20205:46pm
